TrialObesity (Silver Spring, Md.)2019

Pegbelfermin (BMS-986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 Study.

Edgar D Charles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.